Example: Heart Attack

Clinical Trials on Pneumonia, Bacterial

Total 206 results

NCT00538694

Completed

Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia

Conditions: Pneumonia, Bacterial
NCT02459158

Completed

A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia

Conditions: Pneumonia, Bacterial
NCT00111644

Completed

A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia

Conditions: Pneumonia, Bacterial
NCT00540072

Completed

Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae

Conditions: Pneumonia, Bacterial
NCT01969799

Completed

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia

Conditions: Pneumonia, Bacterial
NCT03862040

Terminated

Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia

Conditions: Bacterial Pneumonia
NCT01168713

Completed

Efficacy and Safety Study of Oral CEM-101 Compared to Oral Levofloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Conditions: Community-Acquired Bacterial Pneumonia
NCT01524302

Completed

Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia

Conditions: Pneumonia, Bacterial; Community-acquired
NCT02493764

Completed

Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)

Conditions: Bacterial Pneumonia
NCT01554657

Completed

Five Versus Seven Day Antibiotic Course for the Treatment of Pneumonia in the Intensive Care Unit

Conditions: Pneumonia, Bacterial
NCT03583333

Recruiting

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)

Conditions: Hospital-Acquired Bacterial Pneumonia; Ventilator-Associated Bacterial Pneumonia
NCT02679573

Completed

Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia

Conditions: Community Acquired Bacterial Pneumonia
NCT02605122

Terminated

Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial Pneumonia

Conditions: Community-acquired Bacterial Pneumonia
NCT01968733

Completed

Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Conditions: Community-acquired Bacterial Pneumonia
NCT01756339

Completed

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia

Conditions: Community-acquired Bacterial Pneumonia
NCT01198626

Terminated

Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia

Conditions: Community-Acquired Bacterial Pneumonia (CABP)
NCT01371838

Completed

A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia

Conditions: Community-Acquired Bacterial Pneumonia; Lung Infection of Individual Not Recently Hospitalized
NCT01666743

Withdrawn

Safety and Efficacy Study of Ceftaroline in Elderly Subjects With Community-Acquired Bacterial Pneumonia

Conditions: Community-Acquired Bacterial Pneumonia (CABP)
NCT02218359

Withdrawn

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization

Conditions: Pneumonia, Bacterial
NCT01189487

Completed

The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)

Conditions: Pneumonia, Bacterial
NCT04007328

Recruiting

Sphingosine-1-phosphate and Pneumonia

Conditions: Pneumonia, Bacterial
NCT03551210

Completed

An International, Multicenter, Randomized, Double-blind, Double-dummy, Two-way, Parallel Group, Controlled Study to Compare the Efficacy and Safety of Intravenous and Oral Nemonoxacin Versus Tavanic® in Adult Patients With Community-acquired Pneumonia

Conditions: Pneumonia, Bacterial
NCT04158804

Recruiting

PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs (ProSAVE): A RCT

Conditions: Pneumonia, Bacterial
NCT01799993

Completed

Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia

Conditions: Pneumonia, Bacterial
NCT00797108

Completed

A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization

Conditions: Pneumonia, Bacterial